VITALIPID

This brand name is authorized in Austria, Cyprus, Ecuador, Estonia, Finland, Hong Kong SAR China, Lithuania, New Zealand, Poland, Romania, Singapore, Spain.

Active ingredients

The drug VITALIPID contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII G2SH0XKK91 - RETINOL
 

Vitamin A plays an important role in the visual process. It is isomerised to the 11-cis isomer and subsequently bound to the opsin to form the photoreceptor for vision under subdued light. Vitamin A also participates in the formation and maintenance of the integrity of epithelial tissues and mucous membranes.

 
Read more about Vitamin A
2
UNII VS041H42XC - ERGOCALCIFEROL
 

Vitamin D2 (ergocalciferol) is a fat soluble vitamin. In conjunction with parathyroid hormone and calcitonin, it regulates calcium haemostasis. Ergocalciferol metabolites promote active absorption of calcium and phosphorous by the small intestine, increase rate of excretion and resorption of minerals in bone and promote resorption of minerals in bone and promote resorption of phosphate by renal tubules.

 
Read more about Vitamin D2
3
UNII 7QWA1RIO01 - .ALPHA.-TOCOPHEROL, DL-
 

Vitamin E is known to exert an important physiological function as an antioxidant for fats, with a sparing action on vitamin A, carotenoids and on unsaturated fatty acids. Other work has demonstrated that vitamin E is connected with the maintenance of certain factors essential for the normal metabolic cycle.

 
Read more about Vitamin E
4
UNII A034SE7857 - PHYTONADIONE
 

The presence of vitamin K (i.e. vitamin K or substances with vitamin K activity) is essential for the formation within the body of prothrombin, factor VII, factor IX and factor X. Lack of vitamin K leads to an increased tendency to haemorrhage. When an antidote to an anticoagulant is necessary it is essential to use vitamin K1 itself, as vitamin K analogues are much less effective.

 
Read more about Vitamin K1

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
A11CB Vitamin A and D in combination A Alimentary tract and metabolism → A11 Vitamins → A11C Vitamin A and D, incl. combinations of the two
Discover more medicines within A11CB
B05XC Vitamins B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05X I.V. solution additives
Discover more medicines within B05XC

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria H6030713, H7621013
EE Ravimiamet 1000191, 1000281
ES Centro de información online de medicamentos de la AEMPS 61020, 61021
FI Lääkealan turvallisuus- ja kehittämiskeskus 191064, 191247
HK Department of Health Drug Office 36205, 36206
LT Valstybinė vaistų kontrolės tarnyba 1008243, 1008244
NZ Medicines and Medical Devices Safety Authority 4859, 4860
PL Rejestru Produktów Leczniczych 100070925, 100070931, 100076780, 100293660, 100357615, 100368062, 100369386, 100371934, 100424010, 100430915, 100443480, 100447821
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W43695002, W43696002
SG Health Sciences Authority 05207P, 05208P

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.